<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art15">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73655</ArticleID>
            <ArticleDOI>10.1208/aapsj070365</ArticleDOI>
            <ArticleSequenceNumber>15</ArticleSequenceNumber>
            <ArticleTitle Language="En">It’s time</ArticleTitle>
            <ArticleFirstPage>E655</ArticleFirstPage>
            <ArticleLastPage>E658</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>6</Month>
                <Day>17</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>6</Month>
                <Day>17</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Brian</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Smith</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(317) 277-7315</Phone>
                  <Fax>(317) 277-3220</Fax>
                  <Email>b.smith@lilly.com</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Eli Lilly and Company</OrgDivision>
                <OrgName>Lilly Corporate Center</OrgName>
                <OrgAddress>
                  <Postbox>Drop Code 2233</Postbox>
                  <Postcode>46285</Postcode>
                  <City>Indianapolis</City>
                  <State>IN</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Statistical inference involves taking the results of models and knowledge about probability to make decisions about the relationship in question. This commentary explains the usefulness of statistical inference to the drug development process, as well as some common pitfalls. It also examines reasons why statistical inference does not seem to be fully integrated into pharmacometric modeling. An example is shown that demonstrates the inferential advantages of mechanistic models. Both statisticians and pharmacometricians ought to take note of these advantages and integrate their efforts in order to maximize the decision-making potential of clinical research.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>mechanistic models</Keyword>
              <Keyword>statistical inference</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 24, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73655.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Salsburg</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <BookTitle>The Lady Tasting Tea: How Statistics Revolutionized Science in the Twentieth Century</BookTitle>
                  <PublisherName>Henry Holt and Company</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                </BibBook>
                <BibUnstructured>Salsburg D.<Emphasis Type="Italic">The Lady Tasting Tea: How Statistics Revolutionized Science in the Twentieth Century</Emphasis>. New York: Henry Holt and Company, 2002.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Matthey</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">p&lt;05—But is it clinically significant? Practical examples for clinicians</ArticleTitle>
                  <JournalTitle>Behav Change</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>140</FirstPage>
                  <LastPage>146</LastPage>
                </BibArticle>
                <BibUnstructured>Matthey S. p&lt;05—But is it clinically significant? Practical examples for clinicians.<Emphasis Type="Italic">Behav Change</Emphasis>. 1998;15:140–146.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Dixon</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The p-value fallacy and how to avoid it</ArticleTitle>
                  <JournalTitle>Can J Exp Psychol</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>189</FirstPage>
                  <LastPage>202</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14596477</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1037/h0087425</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Dixon P. The p-value fallacy and how to avoid it.<Emphasis Type="Italic">Can J Exp Psychol</Emphasis>. 2003;57:189–202.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Moye</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <BookTitle>Multiple Analyses in Clinical Trials</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                </BibBook>
                <BibUnstructured>Moye LA.<Emphasis Type="Italic">Multiple Analyses in Clinical Trials</Emphasis>. New York: Springer-Verlag; 2003.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>O’Hagan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Luce</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <BookTitle>A Primer on Bayesian Statistics in Health Economics and Outcomes Research</BookTitle>
                  <PublisherName>Centre for Bayesian Statistics in Health Economics</PublisherName>
                  <PublisherLocation>Sheffield</PublisherLocation>
                </BibBook>
                <BibUnstructured>O’Hagan A, Luce BR.<Emphasis Type="Italic">A Primer on Bayesian Statistics in Health Economics and Outcomes Research</Emphasis>. Sheffield: Centre for Bayesian Statistics in Health Economics 2003; Availble at: &lt;http://www.shef.ac. uk/≈stlao/pdf/primer.pdf.&gt;. Accessed June 1, 2005.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibUnstructured>
                  <Emphasis Type="Italic">SAS/STAT User’s Guide</Emphasis> Version 8. Cary, NC: SAS Institute, Inc. 1999.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
